T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells

Journal of Immunology

Volumn 187, Issue 10, 2011, Pages 5233-5245

  Kalland, Maria Elisabeth ^a,b   Oberprieler, Nikolaus Günter ^a,b,c   Vang, Torkel ^a,b   Taskén, Kjetil ^a,b   Torgersen, Knut Martin ^a,b,d  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c ASTRAZENECA   (United Kingdom)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE B; S6 KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

ANTIGENS, CD2; ANTIGENS, CD28; CELL SEPARATION; G0 PHASE; HUMANS; LYMPHOCYTE ACTIVATION; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; RIBOSOMAL PROTEIN S6; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 81455141913     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101804     Document Type: Article

References (50)

1. Mustelin, T., and K. Taskén. 2003. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371: 15-27. (Pubitemid 36458075)
2. Samelson, L. E. 2002. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu. Rev. Immunol. 20: 371-394. (Pubitemid 34293429)
3. Smith-Garvin, J. E., G. A. Koretzky, and M. S. Jordan. 2009. T cell activation. Annu. Rev. Immunol. 27: 591-619.
4. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70: 585-593.
5. Veillette, A., J. B. Bolen, and M. A. Bookman. 1989. Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes. Mol. Cell. Biol. 9: 4441-4446. (Pubitemid 19239613)
6. Reth, M. 1989. Antigen receptor tail clue. Nature 338: 383-384.
7. Samelson, L. E., M. D. Patel, A. M. Weissman, J. B. Harford, and R. D. Klausner. 1986. Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor. Cell 46: 1083-1090. (Pubitemid 17182732)
8. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274. (Pubitemid 24046689)
9. Chan, A. C., M. Iwashima, C. W. Turck, and A. Weiss. 1992. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 71: 649-662.
10. Zhang, W., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, and L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92: 83-92. (Pubitemid 28053300)
11. Kane, L. P., P. G. Andres, K. C. Howland, A. K. Abbas, and A. Weiss. 2001. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat. Immunol. 2: 37-44. (Pubitemid 33704951)
12. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8: 89-95. (Pubitemid 28097826)
13. Schulze-Luehrmann, J., and S. Ghosh. 2006. Antigen-receptor signaling to nuclear factor kappa B. Immunity 25: 701-715. (Pubitemid 46107295)
14. Tarakhovsky, A., M. Turner, S. Schaal, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374: 467-470.
15. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374: 470-473.
16. Green, J. M., V. Karpitskiy, S. L. Kimzey, and A. S. Shaw. 2000. Coordinate regulation of T cell activation by CD2 and CD28. J. Immunol. 164: 3591-3595. (Pubitemid 30169811)
17. Sasada, T., and E. L. Reinherz. 2001. A critical role for CD2 in both thymic selection events and mature T cell function. J. Immunol. 166: 2394-2403. (Pubitemid 32173474)
18. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T.W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261: 609-612. (Pubitemid 23278372)
19. Meinl, E., D. Lengenfelder, N. Blank, R. Pirzer, L. Barata, and C. Hivroz. 2000. Differential requirement of ZAP-70 for CD2-mediated activation pathways of mature human T cells. J. Immunol. 165: 3578-3583. (Pubitemid 32057259)
20. Kaizuka, Y., A. D. Douglass, S. Vardhana, M. L. Dustin, and R. D. Vale. 2009. The coreceptor CD2 uses plasma membrane microdomains to transduce signals in T cells. J. Cell Biol. 185: 521-534.
21. Melton, E., N. Sarner, M. Torkar, P. A. van der Merwe, J. Q. Russell, R. C. Budd, C. Mamalaki, M. Tolaini, D. Kioussis, and R. Zamoyska. 1996. Transgene-encoded human CD2 acts in a dominant negative fashion to modify thymocyte selection signals in mice. Eur. J. Immunol. 26: 2952-2963. (Pubitemid 26411500)
22. Carmo, A. M., D. W. Mason, and A. D. Beyers. 1993. Physical association of the cytoplasmic domain of CD2 with the tyrosine kinases p56lck and p59fyn. Eur. J. Immunol. 23: 2196-2201. (Pubitemid 23265882)
23. Danielian, S., A. Alcover, L. Polissard, M. Stefanescu, O. Acuto, S. Fischer, and R. Fagard. 1992. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck. Eur. J. Immunol. 22: 2915-2921.
24. Killeen, N., S. G. Stuart, and D. R. Littman. 1992. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J. 11: 4329-4336.
25. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
26. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336. (Pubitemid 36432314)
27. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
28. Khattri, R., T. Cox, S. A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4: 337-342. (Pubitemid 36432315)
29. Sakaguchi, S., M. Miyara, C. M. Costantino, and D. A. Hafler. 2010. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10: 490-500.
30. Miyara, M., Y. Yoshioka, A. Kitoh, T. Shima, K. Wing, A. Niwa, C. Parizot, C. Taflin, T. Heike, D. Valeyre, et al. 2009. Functional delineation and differentiation dynamics of human CD4(+) T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
31. Krutzik, P. O., and G. P. Nolan. 2006. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat. Methods 3: 361-368.
32. Krutzik, P. O., and G. P. Nolan. 2003. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 55: 61-70. (Pubitemid 37522508)
33. Krutzik, P. O., J. M. Irish, G. P. Nolan, and O. D. Perez. 2004. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin. Immunol. 110: 206-221. (Pubitemid 38402001)
34. Oberprieler, N. G., S. Lemeer, M. E. Kalland, K. M. Torgersen, A. J. R. Heck, and K. Tasken. 2010. High-resolution mapping of prostaglandin E2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8 +CD45RO+ T cells. Blood 116: 2253-2265.
35. Krutzik, P. O., J. M. Crane, M. R. Clutter, and G. P. Nolan. 2008. High-content single-cell drug screening with phosphospecific flow cytometry. Nat. Chem. Biol. 4: 132-142.
36. Irish, J. M., J. H. Myklebust, A. A. Alizadeh, R. Houot, J. P. Sharman, D. K. Czerwinski, G. P. Nolan, and R. Levy. 2010. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc. Natl. Acad. Sci. USA 107: 12747-12754.
37. Hagner, P. R., A. Schneider, and R. B. Gartenhaus. 2010. Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. Blood 115: 2127-2135.
38. Valmori, D., A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115: 1953-1962. (Pubitemid 40979735)
39. Michel, F., G. Attal-Bonnefoy, G. Mangino, S. Mise-Omata, and O. Acuto. 2001. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 15: 935-945. (Pubitemid 34075374)
40. Kanner, S. B., N. K. Damle, J. Blake, A. Aruffo, and J. A. Ledbetter. 1992. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling. J. Immunol. 148: 2023-2029.
41. Holdorf, A. D., J. M. Green, S. D. Levin, M. F. Denny, D. B. Straus, V. Link, P. S. Changelian, P. M. Allen, and A. S. Shaw. 1999. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. Exp. Med. 190: 375-384. (Pubitemid 29374835)
42. Bell, G. M., J. Fargnoli, J. B. Bolen, L. Kish, and J. B. Imboden. 1996. The SH3 domain of p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2. J. Exp. Med. 183: 169-178.
43. Veillette, A., M. A. Bookman, E. M. Horak, and J. B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55: 301-308.
44. Rubtsov, Y. P., R. E. Niec, S. Josefowicz, L. Li, J. Darce, D. Mathis, C. Benoist, and A. Y. Rudensky. 2010. Stability of the regulatory T cell lineage in vivo. Science 329: 1667-1671.
45. Crellin, N. K., R. V. Garcia, and M. K. Levings. 2007. Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109: 2014-2022. (Pubitemid 46348201)
46. Liu, G., S. Burns, G. Huang, K. Boyd, R. L. Proia, R. A. Flavell, and H. Chi. 2009. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 10: 769-777.
47. Harada, Y., Y. Harada, C. Elly, G. Ying, J. H. Paik, R. A. DePinho, and Y. C. Liu. 2010. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 207: 1381-1391.
48. Ouyang, W., O. Beckett, Q. Ma, J. H. Paik, R. A. DePinho, and M. O. Li. 2010. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11: 618-627.
49. Kerdiles, Y. M., E. L. Stone, D. R. Beisner, M. A. McGargill, I. L. Ch'en, C. Stockmann, C. D. Katayama, and S. M. Hedrick. 2010. Foxo transcription factors control regulatory T cell development and function. [Published erratum appears in 2011 Immunity 34: 135.] Immunity 33: 890-904.
50. Merkenschlager, M., and H. von Boehmer. 2010. PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J. Exp. Med. 207: 1347-1350.